Drugmaker GlaxoSmithKline has preliminarily agreed to a $3 billion settlement over the sales and marketing practices of several of its drugs, including the diabetes drug Avandia. http://articles.mercola.com/sites/articles/archive/2011/12/01/glaxosmithkline-to-pay-damages-for-avandia.aspx